Heterogeneous effects of gene polymorphism on type 2 diabetes risk: Lesson from the PPARγ2 Pro12Ala

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 9, 2007, Pages 629-631

  Prudente, Sabrina ^a,b   Ludovico, Ornella ^a   Tassi, Vittorio ^a   Trischitta, Vincenzo ^a,b,c  

^a Scientific Institute   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

EDITORIAL; ENVIRONMENT; GENETIC POLYMORPHISM; GENETICS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; ENVIRONMENT; HUMANS; POLYMORPHISM, GENETIC; PPAR GAMMA;

EID: 35348890730     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.07.001     Document Type: Editorial

References (17)

1. Almind K., Doria A., and Kahn C.R. Putting the genes for type II diabetes on the map. Nat Med 7 (2001) 277-279
2. Cooper R.S. Gene-environment interactions and the etiology of common complex disease. Ann Intern Med 139 (2003) 437-440
3. Young S.S., and GE N. Recursive partitioning analysis of complex disease pharmacogenetic studies. I. Motivation and overview. Pharmacogenomics 6 (2005) 65-75
4. Moore J.H. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 4 (2004) 795-803
5. Cocozza S. Methodological aspects of the assessment of gene-nutrient interactions at the population level. Nutr Metab Cardiovasc Dis 17 (2007) 82-88
6. Stumvoll M., and Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 51 (2002) 2341-2347
7. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 (1998) 284-287
8. Ludovico O., Pellegrini F., Di Paola R., Minenna A., Mastroianno S., Cardellini M., et al. Type 2 diabetes risk given by PPARg2 Ala12 variant is heterogeneous across different populations. Obesity 15 (2007) 1-6
9. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
10. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
11. Parikh H., and Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 5 (2004) 151-176
12. Florez J.C., Jablonski K.A., Sun M.W., Bayley N., Kahn S.E., Shamoon H., et al., Diabetes Prevention Program Research Group. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab 92 (2007) 1502-1509
13. Scacchi R., Pinto A., Rickards O., Pacella A., De Stefano G.F., Cannella C., et al. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits. Nutr Metab Cardiovasc Dis (2007)
14. Luan J., Browne P.O., Harding A.H., Halsall D.J., O'Rahilly S., Chatterjee V.K., et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50 (2001) 686-689
15. Memisoglu A., Hu F.B., Hankinson S.E., Manson J.E., De Vivo I., Willett W.C., et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 12 (2003) 2923-2929
16. Pisabarro R.E., Sanguinetti C., Stoll M., and Prendez D. High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care 27 (2004) 2251-2252
17. Vaccaro O., Lapice E., Monticelli A., Giacchetti M., Castaldo I., Galasso R., et al. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients. Diabetes Care 30 (2007 May) 1156-1161